Moneta Group Investment Advisors LLC Astrazeneca PLC Transaction History

Moneta Group Investment Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $194,728 - $233,766	-3,286 Closed	0 $0
Q1 2022 May 11, 2022	BUY	$55.72 - $67.12 $183,095 - $220,556	3,286 New	3,286 $218,000
Q3 2018 Nov 13, 2018	SELL	$34.76 - $39.72 $23,463 - $26,811	-675 Closed	0 $0
Q2 2018 Aug 15, 2018	SELL	$34.55 - $37.05 $449,944 - $482,502	-13,023 Reduced 95.07%	675 $24,000
Q2 2018 Aug 15, 2018	SELL	$34.55 - $37.05 $12,507 - $13,412	-362 Reduced 2.57%	13,698 $24,000
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $444,312 - $476,462	12,860 Added 1071.67%	14,060 $39,000
Q1 2018 May 14, 2018	BUY	$32.97 - $36.63 $39,564 - $43,956	1,200 New	1,200 $42,000

1,358

476M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $196B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Moneta Group Investment Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Moneta Group Investment Advisors LLC with notifications on news.